Paul Geeleher

10PUBLICATIONS
118CO-AUTHORS
Predictive and prognostic markersHaematological tumoursAutomated software engineeringCancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 20, 2026
Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.

|Apr 22, 2026
A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 Medulloblastoma.

|Mar 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

D Bennett, M Wierdl, S Chakraborty

|Dec 15, 2025
An open-source screening platform accelerates discovery of drug combinations.

William C Wright, Min Pan, Gregory A Phelps

|Feb 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid.

Min Pan, Yinwen Zhang, William C Wright

|May 07, 2024
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programs.

Richard H Chapple, Xueying Liu, Sivaraman Natarajan

Pageof 2

Frequent Collaborators

5 joint publications

Richard H Chapple

4 joint publications

Taosheng Chen

4 joint publications

William C Wright

4 joint publications

John Easton